Clinical trial · Interventional
Percutaneous Aponeurotomy in the Treatment of Dupuytren's Disease
NCT02474576CI-TRIAL-00050032APADUPcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The efficiency of percutaneous aponeurotomy in the treatment of Dupuytrens disease is well known. However, the duration of the clinical improvement after aponeurotomy is not well known. This study aims primarily at measuring the incidence rate of local relapse of Dupuytrens-induced finger flessum, within two years following treatment by percutaneous aponeurotomy in Dupuytrens.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Dupuytren Disease | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Percutaneous aponeurotomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Percutaneous aponeurotomy
- description
- Treatment of Dupuytrens-induced finger flessum using percutaneous aponeurotomy
- interventionNames
- Procedure: Percutaneous aponeurotomy
Primary outcomes (1)
- measure
- Frequency of local relapse at 24 months
- timeFrame
- 24 months after treatment by aponeurotomy
- description
- the statistical unit is the finger treated by aponeurotomy (we expect an average of 2 fingers treated for one patient included). Local relapse is defined as the recurrence of a finger flessum superior by 20° to the articular range initially obtained after aponeurotomy
Secondary outcomes (5)
- measure
- Primary success rate of aponeurotomy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient suffers from Dupuytren disease * Patient has at least one finger with at least 20° flessum on the metacarpophalangeal joint and/or on the proximal interphalangeal joint * Patient has chosen to benefit from local treatment Exclusion Criteria: * Pregnancy * Breastfeeding * No social insurance
References
Publications (0)
Data not yet available
No reference posted for this study.